Raam T, McAvoy KM, Besnard A, Veenema AH, Sahay A. Hippocampal oxytocin receptors are necessary for discrimination of social stimuli. Nat Commun. 2017;8(1):2001. doi:10.1038/s41467-017-02173-0
Razquin C, Liang L, Toledo E, et al. Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort study. Int J Cardiol. 2018;253:126-132. doi:10.1016/j.ijcard.2017.10.026
Song J, Kuja-Halkola R, Sjölander A, et al. Specificity in Etiology of Subtypes of Bipolar Disorder: Evidence From a Swedish Population-Based Family Study. Biol Psychiatry. 2018;84(11):810-816. doi:10.1016/j.biopsych.2017.11.014
Sheahan AV, Ellis L. Epigenetic reprogramming: A key mechanism driving therapeutic resistance. Urol Oncol. 2018;36(8):375-379. doi:10.1016/j.urolonc.2017.12.021
Weetman D, Wilding CS, Neafsey DE, et al. Candidate-gene based GWAS identifies reproducible DNA markers for metabolic pyrethroid resistance from standing genetic variation in East African Anopheles gambiae. Sci Rep. 2018;8(1):2920. doi:10.1038/s41598-018-21265-5
Kramer JM, Helfrich C, Levin M, et al. Initial evaluation of the effects of an environmental-focused problem-solving intervention for transition-age young people with developmental disabilities: Project TEAM. Dev Med Child Neurol. 2018;60(8):801-809. doi:10.1111/dmcn.13715
Aslibekyan S, Agha G, Colicino E, et al. Association of Methylation Signals With Incident Coronary Heart Disease in an Epigenome-Wide Assessment of Circulating Tumor Necrosis Factor α. JAMA Cardiol. 2018;3(6):463-472. doi:10.1001/jamacardio.2018.0510
Pasque V, Karnik R, Chronis C, et al. X Chromosome Dosage Influences DNA Methylation Dynamics during Reprogramming to Mouse iPSCs. Stem Cell Reports. 2018;10(5):1537-1550. doi:10.1016/j.stemcr.2018.03.019
Lin YF, Chen CY, Öngür D, et al. Polygenic pleiotropy and potential causal relationships between educational attainment, neurobiological profile, and positive psychotic symptoms. Transl Psychiatry. 2018;8(1):97. doi:10.1038/s41398-018-0144-4
Renneville A, Ben Abdelali R, Chevret S, et al. Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial. Oncotarget. 2014;5(4):916-32. doi:10.18632/oncotarget.1536